Australia Digital Therapeutics Market Size & Outlook
Related Markets
Australia digital therapeutics market highlights
- The Australia digital therapeutics market generated a revenue of USD 18.7 million in 2023 and is expected to reach USD 149.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 34.6% from 2024 to 2030.
- In terms of segment, diabetes was the largest revenue generating application in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
Digital therapeutics market data book summary
| Market revenue in 2023 | USD 18.7 million |
| Market revenue in 2030 | USD 149.6 million |
| Growth rate | 34.6% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
| Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
Other key industry trends
- In terms of revenue, Australia accounted for 0.3% of the global digital therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China digital therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 149.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DarioHealth Corp | View profile | 252 | 322 W. 57th Street, New York, NY, United States, 10011 | https://www.mydario.com |
| Omega Healthcare Investors Inc | View profile | 53 | 303 International Circle, Suite 200, Hunt Valley, MD, United States, 21030 | https://www.omegahealthcare.com |
| Hygeia Healthcare Holdings Co Ltd Ordinary Shares | View profile | 8238 | No. 228 Meiyuan Road, Enterprise Square, Suites 702-707, Jing’an District, Shanghai, China, People's Republic of | https://www.hygeia-group.com.cn |
| Mango Health | View profile | 11-50 | San Francisco, California, United States, North America | http://www.mangohealth.com |
| Akili Inc Ordinary Shares | View profile | 68 | 71 Commercial Street, Mailbox 312, Boston, MA, United States, 02109 | https://www.akiliinteractive.com |
| BioGaia AB Class B | View profile | 211 | Kungsbroplan 3A, Stockholm, Sweden, SE-112 27 | https://www.biogaia.se |
| Fitbit | View profile | 251-500 | San Francisco, California, United States, North America | http://www.fitbit.com |
| Teladoc Health Inc | View profile | 5600 | 2 Manhattanville Road, Suite 203, Purchase, NY, United States, 10577 | https://www.teladochealth.com |
| ResMed Inc | View profile | 10140 | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 | https://www.resmed.com |
Australia digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 31.02% in 2024. Horizon Databook has segmented the Australia digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- Australia Digital Therapeutics Application Outlook (Revenue, USD Million, 2018-2030)
- Others
- CNS Diseases
- Obesity
- Diabetes
- CVD
- Respiratory Diseases
- Smoking Cessation
- Australia Digital Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
- Providers
- Employers
- Others
- Patients
- Payers
Reasons to subscribe to Australia digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia digital therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Australia digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia digital therapeutics market size, by application, 2018-2030 (US$M)
Australia Digital Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
